October 1, 2013 / 11:44 AM / 4 years ago

Walgreen profit beats estimates as generic drug sales rise

Oct 1 (Reuters) - Walgreen Co, the largest U.S. drugstore operator, reported a better-than-expected quarterly profit due to strong sales of higher-margin generic drugs.

Walgreen's net income rose to $657 million, or 69 cents per share, in the fourth quarter ended Aug. 31 from $353 million, or 39 cents per share, a year earlier.

Excluding items, the company earned 73 cents per share. Analysts were expecting 72 cents per share, according to Thomson Reuters I/B/E/S.

Sales rose 5.1 percent to $17.94 billion, just shy of the $17.95 billion analysts had projected.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below